Status: Recruiting
SCRT(Short Course Radiotherapy) Combined With CAPOX Plus QL1706 for Rectal Cancer Liver Metastases
To enhance the treatment efficacy of rectal cancer liver metastasis through a multidisciplinary approach of radiotherapy, immunotherapy, and chemotherapy, and to provide a new direction for the combination treatment strategy.
Participants needed: 42
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Fujian Cancer HospitalUpdated: Mar 3, 2026Locations: 2
Eligibility criteria
Age 18-75 years, any gender. [+8]
Pregnant or lactating women. [+10]